News

ROP is a rare and potentially blinding resulted due to abnormal development of retinal blood vessels in premature babies. The company has presented data from a Rainbow phase

THRUCOOL offers dedicated cold chain services to safeguard the integrity of pharmaceutical and healthcare shipments during air transportation. These include priority uplift and handling, quick ramp transfers at

BARDA is part of the U.S. Health and Human Services Office of the Assistant Secretary for Preparedness and Response. OPTN003, nasal nalmefene, is a potent, long-acting opioid antagonist

The approval of Hulio is based on adoption of positive opinion by the Committee for Medicinal Products for Human Use (CHMP). The CHMP determined that development program, including

Grifols is a global healthcare company based in Spain. Biotest US is a healthcare company based in Florida. According to the complaint, which was announced in August 2018,

Under the terms of the agreement, Shield will receive an immediate £11 million upfront payment, is eligible to receive up to €4.5m in short-term development milestones and up

The ACCC promotes competition and fair trade in markets to benefit consumers, businesses, and the community. ​In May this year, Apotex Australia announced a merger of their Australian

OBI-3424 is a DNA alkylating cancer therapeutic agent that targets aldo-keto reductase 1C3 (AKR1C3) overexpressing cancers. AKR1C3 overexpression has been known to be found in various treatment-resistant and

Dasiglucagon is a potential first-in-class soluble glucagon analog invented and developed by Zealand. It is in development in the ready-to-use HypoPal rescue pen for easy, fast and effective